MADIT poses ethical dilemma for implantable cardioverter defibrillator (ICD) panel
This article was originally published in Clinica
Executive Summary
The deadlock over prophylactic use of ICDs in the US could be broken by publication of the MADIT trial data in a peer review journal. Although the results were presented in full at the North American Society of Pacing and Electrophysiology meeting in May, they are not technically in the public domain as far as the FDA is concerned. The study has been submitted but a publication date has not been announced.